{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:56:51Z","timestamp":1787749011490,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Neurology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.spen.2021.100875","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T13:22:30Z","timestamp":1613049750000},"page":"100875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Tuberous Sclerosis Complex"],"prefix":"10.1016","volume":"37","author":[{"given":"Monica P.","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.spen.2021.100875_bib0001","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pediatrneurol.2014.10.028","article-title":"Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy","volume":"52","author":"Curatolo","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/neup.12515","article-title":"First descriptions of tuberous sclerosis by D\u00e9sir\u00e9-Magloire Bourneville (1840\u20131909)","volume":"38","author":"Brigo","year":"2018","journal-title":"Neuropathology"},{"key":"10.1016\/j.spen.2021.100875_bib0003","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(15)00108-8","article-title":"The road to Vogt's triad","volume":"14","author":"Goodrick","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.1991.tb37742.x","article-title":"Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria","volume":"615","author":"Gomez","year":"1991","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.spen.2021.100875_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/088307389200700219","article-title":"Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association","volume":"7","author":"Roach","year":"1992","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0007","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0883073818768309","article-title":"Vigabatrin for epileptic spasms and tonic seizures in tuberous sclerosis complex","volume":"33","author":"van der","year":"2018","journal-title":"J Child Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0008","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yebeh.2017.02.007","article-title":"Influence of seizures on early development in tuberous sclerosis complex","volume":"70","author":"Capal","year":"2017","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.spen.2021.100875_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pediatrneurol.2014.10.004","article-title":"Tuberous sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND checklist","volume":"52","author":"de Vries","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/dmcn.13352","article-title":"Causes of mortality in individuals with tuberous sclerosis complex","volume":"59","author":"Amin","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0011","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ng0992-37","article-title":"Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease","volume":"2","author":"Kandt","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.spen.2021.100875_bib0013","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1086\/514888","article-title":"Renal cystic disease in tuberous sclerosis: Role of the polycystic kidney disease 1 gene","volume":"61","author":"Sampson","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.spen.2021.100875_bib0014","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/bjo.85.4.420","article-title":"Ophthalmic manifestations of tuberous sclerosis: A population based study","volume":"85","author":"Rowley","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.spen.2021.100875_bib0015","series-title":"Tuberous Sclerosis Complex","author":"Sancak","year":"2005"},{"key":"10.1016\/j.spen.2021.100875_bib0016","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.pediatrneurol.2016.07.003","article-title":"Applying the lessons of tuberous sclerosis: The 2015 Hower Award Lecture","volume":"63","author":"Roach","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0017","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","article-title":"Genetics and molecular biology of tuberous sclerosis complex","volume":"9","author":"Napolioni","year":"2008","journal-title":"Curr Genom"},{"key":"10.1016\/j.spen.2021.100875_bib0018","series-title":"Advances in Genetics","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/bs.adgen.2018.11.003","article-title":"Chapter three - finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies","author":"McEneaney","year":"2019"},{"key":"10.1016\/j.spen.2021.100875_bib0019","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.clpt.6100317","article-title":"Rapamycin: Something old, something new, sometimes borrowed and now renewed","volume":"82","author":"Hartford","year":"2007","journal-title":"Clin Pharmacol Therapeut"},{"key":"10.1016\/j.spen.2021.100875_bib0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): A multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2021.100875_bib0021","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): A multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.spen.2021.100875_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pediatrneurol.2016.04.003","article-title":"Topical use of mammalian target of rapamycin (mTOR) inhibitors in tuberous sclerosis complex-a comprehensive review of the literature","volume":"61","author":"Jozwiak","year":"2016","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0023","series-title":"FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease","year":"2020"},{"key":"10.1016\/j.spen.2021.100875_bib0024","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2019.07.008","article-title":"Preventive antiepileptic treatment in tuberous sclerosis complex: A long-term, prospective trial","volume":"101","author":"Jozwiak","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.spen.2021.100875_bib0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2008-1041360","article-title":"Diagnosis and Management of Neurocutaneous syndromes","volume":"8","author":"Roach","year":"1998","journal-title":"Semin Neurol"}],"container-title":["Seminars in Pediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071909121000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:38:48Z","timestamp":1761028728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071909121000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"alternative-id":["S1071909121000036"],"URL":"https:\/\/doi.org\/10.1016\/j.spen.2021.100875","relation":{},"ISSN":["1071-9091"],"issn-type":[{"value":"1071-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberous Sclerosis Complex","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.spen.2021.100875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100875"}}